|
Volumn 4, Issue 10, 2003, Pages 943-944
|
Unplugging the T cell receptor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
CD69 ANTIGEN;
GAMMA INTERFERON;
INTERLEUKIN 10;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
NEUTRALIZING ANTIBODY;
REACTIVE OXYGEN METABOLITE;
T LYMPHOCYTE RECEPTOR;
T LYMPHOCYTE RECEPTOR ZETA CHAIN;
UNCLASSIFIED DRUG;
ANTIGEN PRESENTING CELL;
ARTICLE;
AUTOIMMUNE DISEASE;
CANCER;
CANCER IMMUNOTHERAPY;
CELL INTERACTION;
DRUG MECHANISM;
GENETIC ENGINEERING;
GRAM NEGATIVE INFECTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOREGULATION;
INFECTION;
INFLUENZA;
INTERFERON PRODUCTION;
LYMPHOCYTE PROLIFERATION;
MACROPHAGE;
MAJOR HISTOCOMPATIBILITY COMPLEX;
NATURAL KILLER CELL;
NONHUMAN;
PORPHYROMONAS GINGIVALIS;
PRIORITY JOURNAL;
RECEPTOR DOWN REGULATION;
T LYMPHOCYTE ACTIVATION;
TH1 CELL;
TUMOR;
ANIMALS;
DOWN-REGULATION;
INTERFERON TYPE II;
LYMPHOCYTE ACTIVATION;
MEMBRANE PROTEINS;
MICE;
RECEPTORS, ANTIGEN, T-CELL;
TH1 CELLS;
|
EID: 0142061079
PISSN: 15292908
EISSN: None
Source Type: Journal
DOI: 10.1038/ni1003-943 Document Type: Article |
Times cited : (3)
|
References (13)
|